NPR's science correspondent answers listener questions about the antiviral drug remdesivir and other COVID-19 treatment possibilities.
Read more on NPR
Friday, 15 May 2020
loobobilly News: What Happened Today: CDC Announces New Guidelines, COVID-19 Treatment Questions
Labels:
Business
,
loobobillyNPR
NPR's science correspondent answers listener questions about the antiviral drug remdesivir and other COVID-19 treatment possibilities.
Read more on NPR
Do You Like This Article
Get Subscribe to Free Email Updates!!
Popular Posts
-
From Obscure To Sold Out: The Story Of Four Seasons Total Landscaping In Just 4 Days The Philadelphia business was the location of a bizarre...
-
Zillionaire To Other Zillionaires: "Pay Up" You probably don't know Nick Hanauer, but he has more money than you. You probably...
-
Should Sex Work Be Decriminalized? Some Activists Say It's Time Opponents of decriminalization say the multi-billion-dollar industry exp...
-
Looking At The Economy's Health Washington Post columnist Catherine Rampell tells NPR's Lulu Garcia-Navarro what she's looking f...
-
A $150 million chip-making tool from a Dutch company has become a lever in the U.S.-Chinese struggle. It also shows how entrenched the globa...
-
Trump Administration's Interest In Syrian Oil Fields Raises Questions President Trump has recently spoken of the need to secure oil fiel...
-
Advanced Micro Devices Inc reported an 18.3 percent jump in quarterly revenue, largely in line with analysts' estimates, but the chipmak...
